Ethical guideposts to clinical trials in oncology
2006
Ethical Guideposts for Clinical Trials in Oncology
publication
Author Information
Author(s): Mark Bernstein
Primary Institution: University of Toronto
Conclusion
The article presents a framework to help ensure the ethical integrity of clinical trials in oncology.
Supporting Evidence
- Ethical issues in clinical research are becoming more prominent as new frontiers are explored.
- Most clinical investigators are well-meaning, but ethical boundaries can be unknowingly transgressed.
- Fully informed consent is crucial yet difficult to achieve in clinical trials.
- Clinical trials must ensure fair and appropriate eligibility criteria to avoid disadvantaging patients.
Takeaway
This article gives doctors a simple guide to make sure they treat patients fairly and ethically when doing cancer research.
Methodology
The article discusses ethical principles and provides a framework for assessing the bioethical integrity of clinical trials.
Potential Biases
Potential biases may arise from financial and non-financial conflicts of interest among clinical investigators.
Limitations
The framework is subjective and reflects the author's beliefs, and no class I evidence is available to support the issues raised.
Want to read the original?
Access the complete publication on the publisher's website